Cord blood cells are easily available and preserved, and they could potentially serve as a routine starting material for isolation and expansion of cells for allogenic as well as authologous ...

Spinal cord injury often triggers a cascade of secondary damage that severely limits functional recovery, largely driven by ...

The findings support that all cell populations within the implant are in a post mitotic state, meaning there was no evidence ...

Researchers at the University of Hong Kong (HKUMed) LKS Faculty of Medicine, and at City University of Hong Kong (CityU) have generated human neural stem cells (hNSCs) that exhibit what they claim is ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced an innovative strategy for the treatment of chronic spinal cord injury (SCI). The company will focus its ...

A series of converging advances in bio-implant technology, from brain-spine interfaces to lab-grown spinal tissue, is bringing the long-elusive goal of spinal cord repair closer to clinical reality.

Netrin1 is a protein that was first characterized for its axon guidance activities during embryonic development. The netrin family has been shown to play many critical roles in developmental and ...

A Phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the long-term safety and feasibility of neural stem cell transplantation for ...

A research team co-led by City University of Hong Kong (CityU) and The University of Hong Kong (HKU) has recently made a significant advancement in spinal cord injury treatment by using genetically ...